Klaria Pharma Holding AB (publ.) (FRA:6FN)
Germany
· Delayed Price · Currency is EUR 0.0404
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:00 AM CET
FRA:6FN Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 10.05 | 2.25 | 8.45 | 5.87 | - | - | Upgrade
|
| Other Revenue | - | - | - | - | 6.11 | 7.22 | Upgrade
|
| Revenue | 10.05 | 2.25 | 8.45 | 5.87 | 6.11 | 7.22 | Upgrade
|
| Revenue Growth (YoY) | 303.82% | -73.41% | 44.07% | -3.99% | -15.35% | -37.59% | Upgrade
|
| Gross Profit | 10.05 | 2.25 | 8.45 | 5.87 | 6.11 | 7.22 | Upgrade
|
| Selling, General & Admin | 14.72 | 11.43 | 15.91 | 10.16 | 9.86 | 8.29 | Upgrade
|
| Research & Development | 24.54 | 22.11 | 24.95 | 51.36 | 63.49 | 48.44 | Upgrade
|
| Other Operating Expenses | - | - | -0.21 | -0.2 | 13.74 | -0.59 | Upgrade
|
| Operating Expenses | 39.26 | 33.53 | 40.64 | 61.31 | 87.09 | 56.15 | Upgrade
|
| Operating Income | -29.21 | -31.29 | -32.18 | -55.44 | -80.97 | -48.93 | Upgrade
|
| Interest Expense | -16.75 | -16.39 | -3.66 | -7.83 | -3.17 | -2.56 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | -0.04 | 0.02 | -0.38 | 0.06 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.02 | -0.02 | 30.53 | 0.06 | Upgrade
|
| Pretax Income | -46.02 | -47.73 | -35.84 | -63.66 | -53.55 | -51.41 | Upgrade
|
| Income Tax Expense | - | 0.02 | -0.06 | 0.12 | -0.01 | 0.03 | Upgrade
|
| Earnings From Continuing Operations | -46.02 | -47.75 | -35.78 | -63.77 | -53.53 | -51.44 | Upgrade
|
| Net Income | -46.02 | -47.75 | -35.78 | -63.77 | -53.53 | -51.44 | Upgrade
|
| Net Income to Common | -46.02 | -47.75 | -35.78 | -63.77 | -53.53 | -51.44 | Upgrade
|
| Shares Outstanding (Basic) | 159 | 125 | 101 | 58 | 52 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 127 | 101 | 58 | 52 | 43 | Upgrade
|
| Shares Change (YoY) | 33.02% | 25.62% | 73.49% | 12.15% | 19.58% | 39.05% | Upgrade
|
| EPS (Basic) | -0.29 | -0.38 | -0.36 | -1.10 | -1.03 | -1.19 | Upgrade
|
| EPS (Diluted) | -0.29 | -0.38 | -0.36 | -1.10 | -1.03 | -1.19 | Upgrade
|
| Free Cash Flow | -31.32 | -11.91 | -9.06 | -49.77 | -24.8 | -35.33 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.09 | -0.09 | -0.86 | -0.48 | -0.81 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -290.63% | -1391.68% | -380.70% | -944.79% | -1324.82% | -677.67% | Upgrade
|
| Profit Margin | -457.90% | -2124.11% | -423.28% | -1086.81% | -875.88% | -712.45% | Upgrade
|
| Free Cash Flow Margin | -311.58% | -529.67% | -107.14% | -848.18% | -405.71% | -489.32% | Upgrade
|
| EBITDA | -13.9 | -20.07 | -21.15 | -45.09 | -70.61 | -36.07 | Upgrade
|
| EBITDA Margin | -138.25% | - | -250.14% | - | - | - | Upgrade
|
| D&A For EBITDA | 15.32 | 11.22 | 11.04 | 10.35 | 10.37 | 12.86 | Upgrade
|
| EBIT | -29.21 | -31.29 | -32.18 | -55.44 | -80.97 | -48.93 | Upgrade
|
| EBIT Margin | -290.63% | - | - | - | - | - | Upgrade
|
| Revenue as Reported | 7.8 | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.